BN Business News
Add your company to Business Communicator →

Business · 06/10/2026

FDA Clears Pralidoxime Chloride Autoinjector for Sale

The US Food and Drug Administration has ruled that the Pralidoxime Chloride Autoinjector, a 600mg/2mL solution, was not withdrawn from the market due to safety or effectiveness concerns.

Source: Federal Register — Health and Human ServicesOpen original release →